Short Summary - October 28. A satisfactory stat
Post# of 7026
(Total Views: 97)
Posted On: 10/28/2022 4:06:44 PM
Short Summary - October 28.
A satisfactory status quo day at .0004 x .0005 - especially considering the majority of the OTC was quiet with many traders put off by losing money continually on the high dilution 10 Billion to 500 Billion O/S tickers and taking a break.
With people failing to hit the ask aggressively at .0005 at the open, there was just 1 x 100K paint down at .0004 from an order placed before the open.
The ask at .0005 was stacked to 50M again - in stages from 37M initially.
Latest DD updated October 23:
https://investorshangout.com/post/view?id=6488563
2022 Revenue for Weeks 1-42 is now $9.549M [before any returns / voided sales]
2022 will easily beat 2021 which was $10.001M.
2022 Q3 was $3.166M in 13 weeks.
2022 Q4 - usually the best Q with Christmas buying - is already $0.635M in 3 weeks with 10 weeks still to go.
Nothing on Week 43 yet from the company - I'll be busy over the weekend but I'll update by Sunday if the company confirms a revenue figure.
A satisfactory status quo day at .0004 x .0005 - especially considering the majority of the OTC was quiet with many traders put off by losing money continually on the high dilution 10 Billion to 500 Billion O/S tickers and taking a break.
With people failing to hit the ask aggressively at .0005 at the open, there was just 1 x 100K paint down at .0004 from an order placed before the open.
The ask at .0005 was stacked to 50M again - in stages from 37M initially.
Latest DD updated October 23:
https://investorshangout.com/post/view?id=6488563
2022 Revenue for Weeks 1-42 is now $9.549M [before any returns / voided sales]
2022 will easily beat 2021 which was $10.001M.
2022 Q3 was $3.166M in 13 weeks.
2022 Q4 - usually the best Q with Christmas buying - is already $0.635M in 3 weeks with 10 weeks still to go.
Nothing on Week 43 yet from the company - I'll be busy over the weekend but I'll update by Sunday if the company confirms a revenue figure.
(0)
(0)SFLMaven, Inc. (SFLM) Stock Research Links
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼